Imaging of inflamed and vulnerable plaque in coronary arteries with 18F-FDG PET/CT in patients with suppression of myocardial uptake using a low-carbohydrate, high-fat preparation

Journal of Nuclear Medicine

Volumn 50, Issue 4, 2009, Pages 563-568

  Wykrzykowska, Joanna ^a,b   Lehman, Sanaz ^a   Williams, Gethin ^a   Parker, J Anthony ^a   Palmer, Matthew R ^a   Varkey, Santosh ^a   Kolodny, Gerald ^a   Laham, Roger ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NONE   (United States)

Author keywords

coronary; imaging; vulnerable plaque

Indexed keywords

FLUORODEOXYGLUCOSE F 18; VEGETABLE OIL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR INFLAMMATION; CARDIOVASCULAR RISK; CARDIOVASCULAR SYMPTOM; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; DIAGNOSTIC IMAGING; DRUG UPTAKE; FEMALE; HEART CATHETERIZATION; HEART MUSCLE; HUMAN; LIPID DIET; LOW CARBOHYDRATE DIET; MALE; NON INVASIVE MEASUREMENT; PATIENT COMPLIANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SELF REPORT;

EID: 63849216723     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.108.055616     Document Type: Article

References (36)

1. Libby P. Changing concepts of atherogenesis. J Intern Med. 2000;247:349-358.
2. Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1994;89:2462-2478.
3. Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of therosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation. 1995;92:1355-1374.
4. 18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;105:2708-2711.
5. Tahara N, Kai H, Ishibashi M, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006;48:1825-1831.
6. 18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol. 2007;49:1533-1539.
7. 18Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol. 2007;50: 892-896.
8. Kahn J. Beyond IVUS: new imaging methods zero in on vulnerable plaque: part II. J Interv Cardiol. 2006;19:27-29.
9. Kooi ME, Cappendijk VC, Cleutjens KB, et al. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected byinvivo magnetic resonance imaging. Circulation. 2003;107:2453-2458.
10. Jaffer FA, Kim DE, Quinti L, et al. Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor. Circulation. 2007;115:2292-2298.
11. Jaffer FA, Libby P, Weissleder R. Molecular imaging of cardiovascular disease. Circulation. 2007;116:1052-1061.
12. Shepherd J, Hilderbrand SA, Waterman P, Heinecke JW, Weissleder R, Libby P. A fluorescent probe for the detection of myeloperoxidase activity in atherosclerosis-associated macrophages. Chem Biol. 2007;14:1221-1231.
13. Reimann AJ, Rinck D, Birinci-Aydogan A, et al. Dual-source computed tomography: advances of improved temporal resolution in coronary plaque imaging. Invest Radiol. 2007;42:196-203.
14. Williams G, Kolodny G. A facile, reproducible method to decrease myocardial FDG uptake in PET studies [abstract]. J Nucl Med. 2006;47(suppl 1):273P.
15. Williams G, Kolodny G. Method for detecting biological active coronary artery disease (CAD) by F18-fluorodeoxyglucose (FDG): positron emission tomography (PET)/computed tomography (CT). Paper presented at: Radiological Society of North America; December 2006; Chicago, Illinois.
16. Frayn K. The glucose-fatty acid cycle: a physiological perspective. Biochem Soc Trans. 2003;31:1115-1119.
17. 18F-FDG by hypermetabolic brown adipose tissue on PET. AJR. 2008;190:1406-1409.
18. 18F-FDG uptake by pre-paringpatientswithahigh-fat, low-carbohydratediet. AJR. 2008;190:W151-W156.
19. Barbaras L, Tal I, Palmer MR, Parker JA, Kolodny GM. Shareware program for nuclear medicine and PET/CT PACS display and processing. AJR. 2007;188: W565-W568.
20. Weissberg PL. Noninvasive imaging of atherosclerosis: the biology behind the pictures. J Nucl Med. 2004;45:1794-1795.
21. Fayad ZA, Fuster V, Fallon JT, et al. Noninvasive in vivo human coronary artery lumen and wall imaging using black-blood magnetic resonance imaging. Circulation. 2000;102:506-510.
22. Amirbekian V, Lipinski MJ, Briley-Saebo KC, et al. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci USA. 2007;104:961-966.
23. Andrews J, Al-Nahhas A, Pennell DJ, et al. Non-invasive imaging in the diagnosis and management of Takayasu's arteritis. Ann Rheum Dis. 2004;63: 995-1000.
24. Zhang Z, Machac J, Helft G, et al. Non-invasive imaging of atherosclerotic plaque macrophage in a rabbit model with F-18 FDG PET: a histopathological correlation. BMC Nucl Med. 2006;6:3.
25. Worthley S, Farouque MO, Worthley M, Baldi M, Chew D, Meredith I. The RADI PressureWire high-sensitivity thermistor and culprit lesion temperature in patients with acute coronary syndromes. J Invasive Cardiol. 2006;18:528-531.
26. Reimann AJ, Kuettner A, Klumpp B, et al. Late enhancement using multi-detector row computer tomography: a feasibility study with low dose 80kV protocol. Eur J Radiol. 2007; 63:10-15.
27. Stamper D, Weissman NJ, Brezinski M. Plaque characterization with optical coherence tomography. J Am Coll Cardiol. 2006;47(8, suppl):C69-C79.
28. Madjid M, Naghavi M, Malik BA, Litovsky S, Willerson JT, Casscells W. Thermal detection of vulnerable plaque. Am J Cardiol. 2002;90:36L-39L.
29. Zarrabi A, Gul K, Willerson JT, Casscells W, Naghavi M. Intravascular thermography: a novel approach for detection of vulnerable plaque. Curr Opin Cardiol. 2002;17:656-662.
30. Verheye S, Van Langenhove G, van Es GA, Serruys P. The percutaneous assessment of regional and acute coronary hot unstable plaques by thermo-graphic evaluation (PARACHUTE) study: a prospective reproducibility and prognostic clinical study using thermography to predict future ischemic cardiac events. Int J Cardiovasc Intervent. 2004;6:69-75.
31. Ishibashi F, Aziz K, Abela GS, Waxman S. Update on coronary angioscopy: review of a 20-year experience and potential application for detection of vulnerable plaque. J Interv Cardiol. 2006;19:17-25.
32. Leber AW, Becker A, Knez A, et al. Accuracy of 64-slice computed tomography toclassifyandquantifyplaquevolumes inthe proximal coronarysystem: acomparative study using intravascular ultrasound. J Am Coll Cardiol. 2006;47:672-677.
33. Becker CR, Nikolaou K, Muders M, et al. Ex vivo coronary atherosclerotic plaque characterization with multi-detector-row CT. Eur Radiol. 2003;13:2094-2098.
34. Nikolaou K, Becker CR, Muders M, et al. Multidetector-row computed tomography and magnetic resonance imaging of atherosclerotic lesions in human ex vivo coronary arteries. Atherosclerosis. 2004;174:243-252.
35. 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke. 2005;36: 2642-2647.
36. 18F-FDG accumulation in atherosclerosis: use of CT and MR co-registration of thoracic and carotid arteries. Eur J Nucl Med Mol Imaging. 2006;33:589-594.